Cargando…

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population

Neutralizing antibody (NAb) detection is critical for evaluating herd immunity and monitoring the efficacy of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, quantitative SARS-CoV-2 antibody levels after vaccination were measured by chemiluminescent immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hee-Jung, Jung, Jin, Lee, Ji Hyun, Lee, Dong-Gun, Kim, Young Bong, Oh, Eun-Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147836/ https://www.ncbi.nlm.nih.gov/pubmed/35632688 http://dx.doi.org/10.3390/v14050946

Ejemplares similares

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population
por: Yin, Qiangling, et al.
Publicado: (2021)

Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
por: Kim, Yoonjoo, et al.
Publicado: (2021)

Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Lee, Beomki, et al.
Publicado: (2022)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Isolation of Antibodies Against the Spike Protein of SARS-CoV from Pig Serum for Competitive Immunoassay
por: Jung, Jaeyong, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
por: Yun, Sojeong, et al.
Publicado: (2021)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity
por: Lee, Nuri, et al.
Publicado: (2021)

Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2
por: Pérez-García, Felipe, et al.
Publicado: (2021)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020)

Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Nickel, Olaf, et al.
Publicado: (2022)

Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
por: Winichakoon, Poramed, et al.
Publicado: (2023)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination
por: Takahashi, Toshihiro, et al.
Publicado: (2023)

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
por: Jääskeläinen, AJ, et al.
Publicado: (2020)

Comprehensive assessment of SARS-CoV-2 antibodies against various antigenic epitopes after naive COVID-19 infection and vaccination (BNT162b2 or ChAdOx1 nCoV-19)
por: Lee, Jihyun, et al.
Publicado: (2022)

Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays
por: Kweon, Oh Joo, et al.
Publicado: (2020)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
por: Harritshøj, Lene H., et al.
Publicado: (2021)

A colorimetric lateral flow immunoassay based on oriented antibody immobilization for sensitive detection of SARS-CoV-2
por: Lee, Ae Sol, et al.
Publicado: (2023)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
por: Lee, Hyeyoung, et al.
Publicado: (2020)

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
por: Šimánek, Václav, et al.
Publicado: (2021)

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
por: Klüpfel, Julia, et al.
Publicado: (2022)

Persistence of the neutralizing antibody response after SARS-CoV-2 infection
por: Shim, Sang-Mu, et al.
Publicado: (2022)

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
por: Jung, Bo Kyeung, et al.
Publicado: (2021)

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022)

Diagnostic Accuracy of Electro-Chemiluminescence Immunoassay Anti-SARS-CoV-2 Serological Test
por: Afzal, Nayab, et al.
Publicado: (2021)

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
por: Takei, Satomi, et al.
Publicado: (2022)

Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
por: Ebanks, Daniel, et al.
Publicado: (2021)

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
por: Kwak, Hye Won, et al.
Publicado: (2023)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021)

Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients
por: Zonneveld, Rens, et al.
Publicado: (2021)

Circulating Antibodies to Skin Bacteria Detected by Serological Lateral Flow Immunoassays Differentially Correlated With Bacterial Abundance
por: Huang, Ryan Yuki, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibodies and Six Immunoassays in Pediatric and Adult Patients 12 Weeks After COVID-19
por: Saglik, Imran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ptpudj739njr64mq1gqu750boc